We have located links that may give you full text access.
Epidemiology of hepatitis C in the United States.
American Journal of Medicine 1999 December 28
Although hepatitis C virus (HCV) infection is the most common chronic blood-bome infection in the United States, the annual incidence of new infections has decreased by more than 80% since 1989 to approximately 36,000 new infections by 1996. The Third National Health and Nutrition Examination Survey (NHANES III) revealed that an estimated 3.9 million US citizens (1.8%) have been infected with HCV. Of these, approximately 2.7 million persons are chronically infected with HCV. Population-based studies indicate that 40% of chronic liver disease is HCV related. Chronic hepatitis C results in an estimated 8,000 to 10,000 deaths each year. Because the prevalence of HCV infection is approximately threefold higher among persons now between 30 and 49 years of age, the number of deaths resulting from HCV-related liver disease could increase substantially during the next 10 to 20 years, as this cohort reaches the ages at which complications from chronic liver disease typically occur. Most people who develop chronic infection may not even be aware that they have been infected, because acute disease is commonly benign. However, infected persons can transmit the disease to others and are at risk for developing chronic liver disease. HCV is transmitted primarily through direct percutaneous exposures to blood. In the United States, blood transfusion accounted for a substantial proportion of HCV infections before 1990, when routine testing began, but now accounts for only a small percentage. Injection drug use is currently the major risk factor for acute HCV infection. Prevention and control of HCV infection in the United States must focus not only on reduction of transmission in groups at high risk of infection (e.g., injection drug users) but also on the early identification of persons with chronic infection.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app